Long non-coding RNA Neat1 triggers renal tubular epithelial cell apoptosis via activating BH3-only protein in membranous nephropathy

References

• Nangaku M, Shankland S, Couser W. Cellular response to injury in membranous nephropathy. J Am Soc Nephrol. 2005;16(5):1195–1204.
   PubMed Web of Science ®Google Scholar
• Ronco P, Debiec H. Pathogenesis of membranous nephropathy: recent advances and future challenges. Nat Rev Nephrol. 2012;8(4):203–213.
   PubMed Web of Science ®Google Scholar
• Ronco P, Debiec H. Molecular pathogenesis of membranous nephropathy. Annu Rev Pathol. 2020;15:287–313.
   PubMed Web of Science ®Google Scholar
• Simon P, Ramée M, Autuly V, et al. Epidemiology of primary glomerular diseases in a french region. Variations according to period and age. Kidney Int. 1994;46(4):1192–1198.
   PubMed Web of Science ®Google Scholar
• Kitajima S, Furuichi K, Sakai N, et al. Relapse and its remission in japanese patients with idiopathic membranous nephropathy. Clin Exp Nephrol. 2015;19(2):278–283.
   PubMed Web of Science ®Google Scholar
• Huang YS, Lu KC, Chao TK, Chen JS, Chen A, et al. Role of melatonin receptor 1A and pituitary homeobox-1 coexpression in protecting tubular epithelial cells in membranous nephropathy. J Pineal Res. 2018;65(1):e12482.
   PubMed Web of Science ®Google Scholar
• Safar-Boueri L, Piya A, Beck LH, Jr, et al. Membranous nephropathy: diagnosis, treatment, and monitoring in the post-PLA2R era. Pediatr Nephrol. 2021;36(1):19–30. :
   PubMed Web of Science ®Google Scholar
• Fernández-Juárez G, Rojas-Rivera J, Logt AV, et al.; STARMEN Investigators. The STARMEN trial indicates that alternating treatment with corticosteroids and cyclophosphamide is superior to sequential treatment with tacrolimus and rituximab in primary membranous nephropathy. Kidney Int. 2021;99(4):986–998.
   PubMedGoogle Scholar
• Zhang L, Li C, Su X. Emerging impact of the long noncoding RNA MIR22HG on proliferation and apoptosis in multiple human cancers. J Exp Clin Cancer Res. 2020;39(1):271.
   PubMed Web of Science ®Google Scholar
• Huang Y, Hsieh H, Shih H, et al. Urinary xist is a potential biomarker for membranous nephropathy. Biochem Biophys Res Commun. 2014;452(3):415–421.
   PubMed Web of Science ®Google Scholar
• Jin LW, Pan M, Ye HY, et al. Down-regulation of the long non-coding RNA XIST ameliorates podocyte apoptosis in membranous nephropathy via the miR-217-TLR4 pathway. Exp Physiol. 2019;104(2):220–230.
   PubMed Web of Science ®Google Scholar
• Jiang X, Li D, Shen W, et al. LncRNA NEAT1 promotes hypoxia-induced renal tubular epithelial apoptosis through downregulating miR-27a-3p. J Cell Biochem. 2019;120(9):16273–16282.
   PubMed Web of Science ®Google Scholar
• Sedger LM, Katewa A, Pettersen AK, et al. Extreme lymphoproliferative disease and fatal autoimmune thrombocytopenia in FasL and TRAIL double-deficient mice. Blood. 2010;115(16):3258–3268.
   PubMed Web of Science ®Google Scholar
• Ke F, Vanyai H, Cowan A, et al. Embryogenesis and adult life in the absence of intrinsic apoptosis effectors BAX, BAK, and BOK. Cell. 2018;173(5):1217–1230.e1217.
   PubMed Web of Science ®Google Scholar
• Eischen C, Roussel M, Korsmeyer S, et al. Bax loss impairs myc-induced apoptosis and circumvents the selection of p53 mutations during myc-mediated lymphomagenesis. Mol Cell Biol. 2001;21(22):7653–7662.
   PubMed Web of Science ®Google Scholar
• Luke J, Van De Wetering C, Knudson C. Lymphoma development in bax transgenic mice is inhibited by bcl-2 and associated with chromosomal instability. Cell Death Differ. 2003;10(6):740–748.
   PubMed Web of Science ®Google Scholar
• Liu J, Yeh C, Huang I, et al. Kuo WJJocp: Signal transducer and activator of transcription 3 mediates apoptosis inhibition through reducing mitochondrial ROS and activating Bcl-2 in gemcitabine-resistant lung cancer A549 cells. 2020.
   Google Scholar
• Goldblatt ZE, Cirka HA, Billiar KL. Mechanical regulation of apoptosis in the cardiovascular system. Ann Biomed Eng. 2021;49(1):75–97.
   PubMed Web of Science ®Google Scholar
• Czabotar PE, Lessene G, Strasser A, et al. Control of apoptosis by the BCL-2 protein family: implications for physiology and therapy. Nat Rev Mol Cell Biol. 2014;15(1):49–63.
   PubMed Web of Science ®Google Scholar
• Lessene G, Czabotar P, Colman P. BCL-2 family antagonists for cancer therapy. Nat Rev Drug Discov. 2008;7(12):989–1000.
   PubMed Web of Science ®Google Scholar
• Wang L, Yang J, Wang H, et al.; Highly expressed ribosomal protein L34 predicts poor prognosis in acute myeloid leukemia and could be a potential therapy target. Highly expressed ribosomal protein L34 predicts poor prognosis in acute myeloid leukemia and could be a poential therapy target. APT. 2020;2(1):32–37. :
   Google Scholar
• Imai H, Hamai K, Komatsuda A, et al. IgG subclasses in patients with membranoproliferative glomerulonephritis, membranous nephropathy, and lupus nephritis. Kidney International. 1997;51(1):270–276.
   PubMed Web of Science ®Google Scholar
• Kuroki A, Shibata T, Honda H, et al. Glomerular and serum IgG subclasses in diffuse proliferative lupus nephritis, membranous lupus nephritis, and idiopathic membranous nephropathy. Intern Med. 2002;41(11):936–942.
   PubMed Web of Science ®Google Scholar
• Hsu SI, Couser WG. Chronic progression of tubulointerstitial damage in proteinuric renal disease is mediated by complement activation: a therapeutic role for complement inhibitors? J Am Soc Nephrol. 2003;14(7 Suppl 2):S186–S191.
   PubMed Web of Science ®Google Scholar
• Tang S, Lai KN, Sacks SH. Role of complement in tubulointerstitial injury from proteinuria. Kidney Blood Press Res. 2002;25(2):120–126.
   PubMed Web of Science ®Google Scholar
• Li CH, Chen Y. Targeting long non-coding RNAs in cancers: progress and prospects. Int J Biochem Cell Biol. 2013;45(8):1895–1910.
   PubMed Web of Science ®Google Scholar
• Yi H, Peng R, Zhang LY, et al. LincRNA-Gm4419 knockdown ameliorates NF-κB/NLRP3 inflammasome-mediated inflammation in diabetic nephropathy. Cell Death Dis. 2017;8(2):e2583.
   PubMedGoogle Scholar
• Yang Y, Xue M, Jia Y, et al. Long noncoding RNA NEAT1 is involved in the protective effect of klotho on renal tubular epithelial cells in diabetic kidney disease through the ERK1/2 signaling pathway. Exp Mol Med. 2020;52(2):266–280.
   PubMed Web of Science ®Google Scholar
• Song H, Han IY, Kim Y, et al. The NADPH oxidase inhibitor DPI can abolish hypoxia-induced apoptosis of human kidney proximal tubular epithelial cells through Bcl2 up-regulation via ERK activation without ROS reduction. Life Sci. 2015;126:69–75.
   PubMed Web of Science ®Google Scholar
• Gao C, Zou X, Chen H, et al. Long Non-Coding RNA nuclear paraspeckle assembly transcript 1 (NEAT1)relieves Sepsis-Induced kidney injury and lipopolysaccharide (LPS)-induced inflammation in HK-2 cells. Med Sci Monit. 2020;26:e921906.
   PubMed Web of Science ®Google Scholar
• Singh R, Letai A, Sarosiek K. Regulation of apoptosis in health and disease: the balancing act of BCL-2 family proteins. Nat Rev Mol Cell Biol. 2019;20(3):175–193.
   PubMed Web of Science ®Google Scholar